Life-threatening haematemesis associated with clozapine: A case report and literature review

2Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Clozapine is regarded as a second-line and in some cases last-line antipsychotic known for its common life-threatening side effects, such as agranulocytosis, constipation and cardiomyopathies, but rarely haematemesis. We report a case of severe haemetemesis in a chronic schizophrenic patient managed with clozapine. The patient was a 46-year-old male being managed for chronic schizophrenia with treatment resistance who developed sudden severe haematemesis following commencement of clozapine for 6 weeks. The patient had 1.1 l of blood transfusion. The relevant literature is reviewed. Clozapine can be associated with a life-threatening haematemesis. Psychiatrists and other medical specialists need to be alert to the fatality of clozapine-induced haematemesis in the treatment of psychiatric disorders. © 2013, SAGE Publications. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Adebayo, K. O., Ibrahim, N., Mosanya, T., Eegunranti, B., Suleiman, B., & Ayankunle, A. (2013). Life-threatening haematemesis associated with clozapine: A case report and literature review. Therapeutic Advances in Psychopharmacology, 3(5), 275–277. https://doi.org/10.1177/2045125313481026

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free